In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Biotin Forte Drug Master File in Korea (Biotin Forte KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Biotin Forte. The MFDS reviews the Biotin Forte KDMF as part of the drug registration process and uses the information provided in the Biotin Forte KDMF to evaluate the safety and efficacy of the drug.
After submitting a Biotin Forte KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Biotin Forte API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Biotin Forte suppliers with KDMF on PharmaCompass.